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Abstract: Coagulase-negative staphylococci (CoNS) are gaining much attention as causative agents
of serious nosocomial infections in humans. This study aimed to determine the prevalence and
phenotypic antimicrobial resistance of CoNS as well as the presence of resistance-associated genes
in CoNS isolated from turkey farms in Egypt. Two hundred and fifty cloacal swabs were collected
from apparently healthy turkeys in Egypt. Suspected isolates were identified by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The susceptibility
testing of CoNS isolates against 20 antimicrobial agents was performed using the broth microdilution
test. The presence of resistance-associated genes like mecA, vanA, blaZ, erm(A), erm(B), erm(C),
aac-aphD, optrA, valS, and cfr was determined. Thirty-nine CoNS were identified. All isolates were
phenotypically resistant to trimethoprim/sulfamethoxazole, penicillin, ampicillin, and tetracycline.
The resistance rates to erythromycin, chloramphenicol, oxacillin, daptomycin, and tigecycline were
97.4%, 94.9%, 92.3%, 89.7%, and 87.2%, respectively. Thirty-one isolates were resistant to linezolid
(79.5%). Low resistance rate was detected for both imipenem and vancomycin (12.8%). The erm(C)
gene was identified in all erythromycin phenotypically resistant isolates, whereas two resistant
isolates possessed three resistance-conferring genes erm(A), erm(B), and erm(C). The cfr and optrA
genes were detected in 11 (35.5%) and 12 (38.7%) of the 31 linezolid-resistant isolates. The mecA,
aac-aphD, and blaZ genes were identified in 22.2%, 41.9%, and 2.6% of phenotypically resistant isolates
to oxacillin, gentamicin, and penicillin, respectively. This is the first study revealing the correlation
between linezolid resistance and presence of cfr and optrA genes in CoNS isolates from Egypt, and it
can help to improve knowledge about the linezolid resistance mechanism.
Keywords: staphylococci; linezolid; CoNS; Turkey; Egypt
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1. Introduction
Coagulase-negative staphylococci (CoNS) are commonly found in animals, humans, food, and the
environment. They were believed to be nonpathogenic bacteria until 1980. Thereafter, they have
gained more attention as causative agents of serious nosocomial infections in humans [1].
CoNS have also proven to be pathogenic in poultry, causing decreased weight gain, drop in egg
production, endocarditis, and increased mortalities [2].
Although CoNS infections are less severe than Staphylococcus aureus infections, their treatment has
been shown to be more complicated because of the dramatic increase in antibiotic resistance, especially
for penicillin, oxacillin/methicillin, gentamicin, clindamycin, ciprofloxacin, and erythromycin [1].
CoNS have a feature of rapid acquisition, possessing, and modification of resistance genes. This feature
further promotes the transmission of these genes into different staphylococcal species or even other
bacterial genera [1,3]. Infections caused by antibiotic-resistant CoNS have been increasing in humans
worldwide. However, only few studies have discussed the presence of CoNS in humans and animals
in Egypt [4–6].
Linezolid (oxazolidinone class) is a last-resort antimicrobial agent for the control of serious
infections caused by methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci
in humans [7]. The oxazolidinone resistance is attributed to both chromosomal mutations and the
acquisition of a transferable plasmid-borne ribosomal methyltransferase gene (cfr) [8]. The cfr gene
targets the adenine residue at position A2.503 in the 23S rRNA gene and prevents the binding of drugs
belonging to at least five antimicrobial classes, including oxazolidinones, phenicols, lincosamides,
pleuromutilins, and streptogramin A [9].
The optrA gene conferring resistance to oxazolidinones and cross-resistance to phenicols is
associated with linezolid and tedizolid resistance [10]. Both optrA and cfr genes were identified in a
multiresistance plasmid in florfenicol-resistant Staphylococcus sciuri isolated from pigs in China [11].
Linezolid resistance is increasing more intensely in CoNS than in S. aureus [12,13]. However,
reports discussing this problem in animals are rarely available [14].
Moreover, resistance of CoNS to linezolid has not yet been reported in Egypt, neither in humans
nor in animals. Many investigations in other countries have shown that linezolid-resistant staphylococci
are still susceptible to daptomycin and tigecycline [8,12]. Daptomycin is a novel cyclic lipopeptide
with great activity against most Gram-positive pathogens, including strains resistant to methicillin and
vancomycin [15]. Nonetheless, the inappropriate dosing of daptomycin has resulted in the emergence
of resistance in staphylococci. The resistance against daptomycin in CoNS has now been reported in
humans, although it has not yet been recorded in veterinary medicine [16].
Novel formulations and potential drugs have been synthesized and evaluated for biological
activity with high impact on relatively resistant microorganisms, and they exhibited a strong in vitro
antimicrobial activity in susceptibility assays [17].
The aim of the present study was to determine the antimicrobial resistance of CoNS isolated from
apparently healthy turkeys housed in different governorates of the Nile Delta in Egypt.
2. Materials and Methods
2.1. Sampling and Bacterial Isolation
During 2018, 250 cloacal swabs were collected from apparently healthy turkeys, aged between
6 days and 365 days and housed in 12 epidemiologically nonrelated farms located in five governorates
(Dakahlia, Damietta, Kafr El-Sheikh, Sharkiya, and Gharbiya) in the Nile Delta region in Egypt (Table 1).
All farms were designed as closed systems except one farm, which was an open system located
in the Sharkiya governorate. The antimicrobial drugs used in turkey flocks in Egypt were applied
as growth promoters (digestion-enhancing antibiotics), prophylactics, and therapeutics. The main
antibiotics used in farms were chlortetracycline, fluoroquinolones, colistin, tylosin, spectinomycin,
chloramphenicol, and sulfonamides. The hygienic measures in the farms were of moderate or low
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standards. The watering systems were designed as tap water distribution drinkers inside the farms.
The workers were allowed to move between flocks for food distribution and cleaning.




Dakahliya Damietta Kafr El-Sheikh Sharkiya Gharbiya 5
Farms * 4 3 2 2 1 12
Birds 5000 2100 1200 1800 800 10,900
Samples 71 44 46 46 43 250
* Each farm reared one flock.
The collected swab samples were transported at 4 ◦C to the laboratory for microbiological
examination. Thereafter, samples were pre-enriched in buffered peptone water and incubated
aerobically at 37 ◦C for 24 h. Enriched bacterial samples were streaked on Columbia blood agar
containing 5% defibrinated sheep blood at 37 ◦C for 24 and 48 h as primary cultivation for the
isolation of staphylococci. The suspected colonies were further streaked on Baird–Parker agar (Oxoid
GmbH, Wesel, Germany) and incubated aerobically at 37 ◦C for 24 h to identify S. aureus and other
Staphylococcus spp. The black colonies were subsequently picked and identified by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).
2.2. Identification of Bacterial Isolates by MALDI-TOF MS
Suspected colonies were identified using MALDI-TOF MS using an Ultraflex instrument (Bruker
Daltonik GmbH, Bremen, Germany). Analysis was carried out using the Biotyper 3.1 software
(Bruker Daltonik GmbH). Interpretation of results was performed according to the manufacturer′s
recommendations: a score of ≥2.3 represented reliable species-level identification, a score of 2.0–2.29
represented probable species-level identification, a score of 1.7–1.9 represented probable genus-level
identification, and a score of ≤1.7 was considered an unreliable identification [18].
2.3. Phenotypic Antimicrobial Susceptibility Testing
The antibiotic susceptibility testing of all isolates to 20 antimicrobial agents was performed
by the MICRONAUT system using commercial 96-well microtiter plates (Merlin, Gesellschaft für
mikrobiologische Diagnostika mbH, Bornheim-Hersel, Germany) as recommended by the manufacturer.
Briefly, bacteria grown overnight were suspended in NaCl solution (0.9%) to obtain a turbidity
corresponding to a McFarland standard of 0.5 (Dr. Lange, CADAS photometer 30, Berlin, Germany).
One hundred microliters of the suspension were diluted in 10 ml of Mueller–Hinton broth (Oxoid
GmbH), resulting in a concentration of approximately 106–107 colony-forming units (cfu)/mL. In total,
100 µL of the inoculum were given in each well of the plate. The plates were aerobically incubated for
18–24 h at 37 ◦C. Reading of plates was operated with a photometer (Merlin) at a wavelength of 620 nm.
An optical density of >0.1 was interpreted as an indication of growth. Tested antimicrobial agents,
classes, concentrations, and the breakpoints are given in Table 2. The results were interpreted according
to guidelines of the Clinical and Laboratory Standards Institute (CLSI) and the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) [19,20]. Escherichia coli (E. coli) ATCC 25922 and
S. aureus ATCC 29213 were used as quality controls.
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Table 2. Antibiotic susceptibility of 39 coagulase-negative Staphylococcus isolates from turkey flocks determined by broth microdilution test.
Antibiotic Class 0.03125 0.0625 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 R (%) MIC50(mg/L)
MIC90
(mg/L)
Amikacin (AMK) # Aminoglycoside 3 2 5 6 23 29 (74.4) 64 64
Ampicillin (AMP) * β-Lactam (Penicillin) 22 3 14 39 (100) 2 16
Cefoxitin (COX) * β-Lactam (Cephalosporin) 10 3 1 25 29 (74.4) 16 16
Chloramphenicol (CMP) * Miscellaneous 2 2 35 37(94.9) 64 64
Ciprofloxacin (CIP) # Fluoroquinolone 2 5 6 26 32(82) 4 4
Daptomycin (DPT) * Cyclic lipopeptide 3 1 35 35 (89.7) 4 4
Erythromycin (ERY) # Macrolide 1 2 36 38 (97.4) 8 8
Gentamicin (GEN) # Aminoglycoside 6 2 5 3 23 31 (79.5) 8 8
Imipenem (IMP) * β-Lactam (Carbapenem) 8 8 7 4 3 4 2 3 5 (12.8) 0.5 8
Levofloxacin (LEV) # Fluoroquinolone 5 2 2 30 32 (82) 4 4
Linezolid (LIZ) # Oxazolidinone 5 3 4 27 31 (79.5) 16 16
Moxifloxacin (MOX) * Fluoroquinolone 2 3 2 32 32 (82) 2 2
Oxacillin (OXA) * β-Lactam(Penicillin) 3 6 3 3 4 20 36 (92.3) 16 16
Penicillin (PEN) * β-Lactam (Penicillin) 3 3 33 39 (100) 8 8
Rifampicin (RAM) * Ansamycin 11 28 28 (71.8) 4 4
Teicoplanin (TPL) # Glycopeptide 6 20 6 7 13 (33.3) 2 16
Tetracycline (TET) # Tetracycline 4 35 39 (100) 16 16
Tigecyclin (TGC) * Glycylcycline 3 1 1 34 34 (87.2) 1 1
Trimethoprim/Sulfamethoxazole (T/S) * Diaminopyrimidine/Sulfonamide 39a* 39 (100) 4/76 4/76
Vancomycin (VAN) # Glycopeptide 10 9 8 7 4 1 5 (12.8) 2 8
A thick black line indicates the break point between clinically sensitive and resistant strains; R—resistance rate. # EUCAST; * CLSI.
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2.4. DNA Extraction and Purification
DNA was extracted from bacterial cultures using High Pure PCR Template Purification Kit (Roche
Diagnostics, Mannheim, Germany) according to the instructions of the manufacturer. DNA concentration
was determined photometrically using a NanoDrop ND-1000 UV–VIS spectrophotometer (NanoDrop
Technologies, Wilmington, NC, USA). The DNA was stored at −20 ◦C for further investigations.
2.5. Identification of Resistance-Associated Genes
The potential mechanisms underlying the antimicrobial resistance of methicillin, erythromycin,
penicillin, and aminoglycosides were detected by amplifying the mecA, erm(A), erm(B), erm(C), blaZ,
and aac-aphD genes, respectively, as described previously [21]. The vanA gene associated with
vancomycin resistance was amplified according to Okolie et al., 2015 [22].
The presence of three different genes (optrA, valS, and cfr) responsible for linezolid resistance was
determined by PCR. The primer sequences are given in Table 3. PCR for detection of the valS gene
was developed in this study as follows: an initial denaturation step at 96 ◦C for 60 s was followed
by 35 cycles of denaturation (96 ◦C for 15 s), annealing (51 ◦C for 60 s), and extension (72 ◦C at 30 s),
with a final extension at 72 ◦C for 60 s. PCR amplicon of 339 bp was considered positive. PCRs for
detection of optrA and cfr genes have been described previously [23]. PCR products were analyzed on
1.5% agarose gel, stained with ethidium bromide, and visualized under UV light.
Table 3. Primers and their sequences used in this study.
Gene Antimicrobial Agent Primer Primer Sequence (5′–3′) Reference
mecA Methicillin/Oxacillin
mecA-F TCC AGA TTA CAA CTT CAC CAG G
[21]
mecA-R CCA CTT CAT ATC TTG TAA CG
erm(A)
Erythromycin
ermA-F TAT CTT ATC GTT GAG AAG GGA TT
ermA-R CTA CAC TTG GCT TAG GAT GAA A
erm(B) ermB-F CTA TCT GAT TGT TGA AGA AGG ATT
ermB-R GTT TAC TCT TGG TTT AGG ATG AAA
erm(C) ermC-F CTT GTT GAT CAC GAT AAT TTC C
ermC-R ATC TTT TAG CAA ACC CGT ATT C
blaZ Penicillin
blaZ-F ACT TCA ACA CCT GCT GCT TTC
blaZ-R TGA CCA CTT TTA TCA GCA ACC
aac-aphD Gentamicin, amikacin aac-aphD-F TAA TCC AAG AGC AAT AAG GGC
aac-aphD-R GCC ACA CTA TCA TAA CCA CTA
vanA Vancomycin
vanA.F GCT GTG AGG TCG GTT GTG [22]
vanA.R GCT CGA CTT CCT GAT GAA TAC G
optrA Linezolid,
chloramphenicol
optrA-F AGG TGG TCA GCG AAC TAA [23]
optrA-R ATC AAC TGT TCC CAT TCA
valS Linezolid
valS-F GTA ACG ATC ATC ATT TGG G This study
valS-R CTT TAT TAG AGC TCA ATG GGC
cfr Oxazolidinones
Cfr-F TGA AGT ATA AAG CAG GTT GGG AGT CA [23]
Cfr-R ACC ATA TAA TTG ACC ACA AGC AGC
3. Results
3.1. Isolation and Identification of Staphylococcus spp. Isolated from Turkeys
Out of 250 cloacal samples, 39 (15.6 %) CoNS isolates were identified from 12 turkey flocks
in five governorates in Egypt using MALDI-TOF MS (Table 4). The species were classified as
Staphylococcus lentus (n = 16), Staphylococcus xylosus (n = 8), Staphylococcus saprophyticus (n = 5), S. sciuri
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(n = 3), Staphylococcus condimenti (n = 2), Staphylococcus cohnii (n = 2), Staphylococcus simulans (n = 1),
Staphylococcus epidermidis (n = 1), and Staphylococcus arlettae (n = 1).
Table 4. Presence of antibiotic resistance genes in coagulase-negative Staphylococcus spp. and phenotypic
linezolid resistance.
Isolate





S. lentus erm(B), erm(C), valS 8
0275-1 365 S. sciuri mecA, erm(C), optrA, valS 8
0275-2 365 S. lentus mecA, erm(C) 1
0281-1 365 S. condimenti erm(C) 1
0283-1 365 S. sciuri mecA, erm(B), erm(C), aac-aphD, valS, cfr 8
0286-2 365 S. lentus erm(B), erm(C), valS, cfr 8
0288-2 365 S. condimenti erm(C) 2
0294 6 S. xylosus erm(B), erm(C), optrA, valS 8
0298 6 S. saprophyticus erm(C), valS, cfr 8
0300 6 S. saprophyticus erm(C), optrA, valS, cfr 8
0303 6 S. lentus erm(A), erm(B), erm(C), aac-aphD, optrA,valS, cfr 8
0306 240
Damietta
S. lentus erm(C), optrA, valS 8
0307-2 240 S. xylosus erm(C), valS 8
0310-2 240 S. xylosus erm(C), valS 8
0311 240 S. lentus mecA, erm(C), valS, cfr 8
0312-1 240 S. xylosus erm(C), valS 8
0314 240 S. xylosus erm(C), aac-aphD, valS 8
0314-1 240 S. lentus erm(B), erm(C), aac-aphD, optrA 8
0316 240 S. lentus erm(B), erm(C), optrA, valS, cfr 8
0317 240 S. lentus erm(B), erm(C), optrA, valS, cfr 8
0318-1 240 S. lentus erm(C), valS 8
0321-1 240 S. xylosus erm(C), aac-aphD, valS 8
0322-2 240 S. sciuri mecA, erm(C), aac-aphD, valS 8
0323-2 240 S. xylosus erm(B), erm(C), valS 2
0327 240 S. arlettae erm(A), erm(B), erm(C), valS, cfr 8
0330-1 240 S. cohnii - 1
0336 10 S. saprophyticus erm(B), erm(C), aac-aphD, optrA, valS 8
0338 10 S. cohnii erm(B), erm(C), aac-aphD 1
0339-2 10 S. xylosus erm(C), aac-aphD, optrA 8
0340 21
Sharkiya
S. lentus erm(C), valS, cfr 8
0346 21 S. saprophyticus erm(B), erm(C), aac-aphD, optrA, valS, cfr 8
0347-2 21 S. saprophyticus mecA, erm(B), erm(C), aac-aphD 1
0349 21 S. lentus erm(C), aac-aphD, valS 8
0353-1 75 S. lentus erm(C), valS 2
0358 75 S. lentus erm(C), valS 8
0366 75 S. lentus erm(C), valS 8
0368 60 Kafr
El-Sheikh
S. simulans mecA, erm(C), valS 8
0370 60 S. lentus erm(B), erm(C), aac-aphD, valS 8
0397 123 Gharbia S. epidermidis mecA, blaZ, erm(B), erm(C), optrA, valS 8
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3.2. Phenotypic Antimicrobial Resistance Profiles
The diversity in phenotypic antibiotic susceptibility profiles of 39 CoNS isolates against 20 antimicrobial
agents and their classes is shown in Table 2. All isolates were resistant to trimethoprim/sulfamethoxazole,
penicillin, ampicillin, and tetracycline. Evident resistance rates were recorded to erythromycin 97.4%,
chloramphenicol 94.9%, oxacillin 92.3%, daptomycin 89.7%, and tigecycline 87.2%. Resistance to
moxifloxacin, levofloxacin, and ciprofloxacin was 82% each. Thirty-one isolates were resistant to
linezolid (79.5%). Low resistance rate (12.8%) was detected for both imipenem and vancomycin.
All resistant isolates to ciprofloxacin and gentamicin were additionally resistant to oxacillin.
Additionally, all oxacillin-resistant isolates were resistant to chloramphenicol and tetracycline.
The resistance rates for gentamicin, cefoxitin, amikacin, rifampicin, and teicoplanin were 79.5%,
74.4%, 74.4%, 71.8%, and 33.3%, respectively. All isolates were resistant to at least three different classes
of antimicrobial agents, so they were all defined as having multidrug resistance (MDR).
3.3. Prevalence of Antimicrobial Resistance-Associated Genes
The erm(C), erm(B), and erm(A) genes were identified in 97.4%, 41.0%, and 5.12% of all CoNS
isolates, respectively. All phenotypically resistant isolates to erythromycin carried the erm(C) gene.
Two phenotypically resistant CoNS isolates (17CS0303 and 17CS0327; ≥ 8 mg/L) were positive for the
three screened genes erm(A), erm(B), and erm(C) (Table 4).
Eight out of 36 (22.2%) phenotypically oxacillin-resistant isolates possessed the mecA gene.
Additionally, these eight isolates were resistant to ciprofloxacin and gentamicin. The vanA gene could
not be detected by PCR in any of the phenotypically vancomycin-resistant isolates. The aac-aphD
gene was detected in 41.9% and 20.7% of gentamicin- and amikacin-resistant isolates, respectively.
The blaZ gene associated with penicillin G resistance was identified only in one isolate (2.6%), which
was phenotypically resistant to penicillin and ampicillin. The cfr gene was identified in 11 (28.2%) of
all isolates. All isolates harboring the cfr gene were phenotypically resistant to chloramphenicol and
linezolid. The optrA gene was found in 12 out of 36 (38.7%) isolates that showed phenotypic resistance
to linezolid (Table 4). The valS gene was identified in all linezolid-resistant isolates. Five CoNS isolates
carried all three genes (cfr, optrA, or valS), while 11 isolates harbored two of these genes (Table 4).
All isolates carrying two or three of these genes were resistant to linezolid (≥ 8mg/L (Table 4)).
Two different Staphylococcus species (S. xylosus 17CS0314 and S. lentus 17CS0314-1), isolated from
an individual bird exhibited two different phenotypic and genotypic resistance profiles (Table 4).
Eleven CoNS (28.2%) isolated from poults (6–21 days) exhibited multidrug resistance and harbored
antibiotic resistance-associated genes.
4. Discussion
The poultry industry is one of the most important sources of the Egyptian economy. However,
turkey production is still limited to a small scale. Very few data are available about turkey production
and diseases in Egypt [24].
CoNS are implicated in serious infections in both humans and animals and show high resistance
to several antibiotics [25].
Few studies have investigated the presence of CoNS in poultry [26–28] and studies discussing the
presence of CoNS in turkeys are rare globally [29]. Moreover, no data about their prevalence in turkeys
in Egypt exist at all.
The current perceptions and approaches to antibiotic resistance in food animal production,
especially in poultry in Egypt, are not like in other countries with developed commercial poultry
farming sectors. In Egypt, various combinations of constraints in veterinary and human medicine have
been identified, such as the lack of legislation, knowledge, resources, and veterinary services. These
constraints act as obstacles that hamper the prudent use of antimicrobial drugs. The antimicrobial
drugs used in poultry production in Egypt are applied for growth promotion (digestion-enhancing
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antibiotics) and prophylaxis besides treatment of infections. There are no proper legislations in place
to regulate the sale of antimicrobial drugs used for poultry production in Egypt.
The current study showed that CoNS isolated from healthy turkeys had high phenotypic resistance
to all β-lactams except imipenem, which is prescribed as one of the first line of defense drugs against
clinical infections caused by staphylococci. The rates of resistance were as follows: 100% for penicillin
and ampicillin, 92.3% for oxacillin, 74.4% for cefoxitin, and low resistance to imipenem (12.8%). These
results are in accordance with previous reports stating that β-lactam resistance in CoNS is greatly
increasing [30].
The blaZ gene is responsible for penicillin resistance [31]. Although all isolates in the present
investigation were phenotypically resistant to penicillin and ampicillin, the blaZ gene was detected
in only one isolate (2.6%), showing discrepancy between phenotypic resistance and detection of
β-lactamase gene blaZ. β-lactamase phenotype could be the result of expression of more than one gene.
Moreover, there is more than one mechanism that grant staphylococci β-lactam resistance other than
the expression of blaZ gene [32]. On the contrary, previous studies found higher prevalence (23.0% and
20.0%) for the blaZ gene in CoNS isolated from mastitis in cattle in Argentina [33].
In the current study, it was strongly noticed that all isolates showed MDR to at least three different
classes of antimicrobial agents. The β-lactam resistance was additionally associated with resistance
to other clinically important antibiotics, including tetracycline (100%), fluoroquinolones (82% for
levofloxacin, moxifloxacin, and ciprofloxacin), aminoglycosides (gentamicin 79.5% and amikacin
74.4%), macrolides (erythromycin 97.43%), and glycopeptides (teicoplanin 33.3% and vancomycin
12.8%). This could be attributed to the fact that resistance mechanisms for these classes of antibiotics
are similar and usually carried with the genetic elements responsible for β-lactam resistance on the
same plasmids [34]. Resistance rates to β-lactams in this study were significantly higher than results of
previous studies discussing antibiotic resistance of CoNS in humans [12,35] and poultry [26,36].
In this study, an evident resistance rate (92.3%) against oxacillin (β-lactam) was detected. This
result was significantly higher than those reported in previous studies in Egypt discussing methicillin
resistance in CoNS of human sources (75.9%) [5] and those from chicken meat (37%) [6].
The mecA gene is associated with resistance to methicillin/oxacillin, often in combination with
ciprofloxacin, gentamicin, and vancomycin resistance [37]. It was detected in only 8 out of 36 isolates
that showed phenotypic oxacillin resistance. This incompatible result is similar to findings of oxacillin
resistance with absence of mecA gene that was reported earlier [38].
Previously, fluoroquinolones, such as ciprofloxacin and levofloxacin, were effective against
methicillin-resistant bacteria. However, the misuse of these drugs has resulted in decreasing
effectiveness [39].
Phenotypic resistance to trimethoprim/sulfamethoxazole was detected in all isolates in this study,
which could be attributed to the massive use of these antibiotics as growth promoters in poultry farms
in Egypt [24].
Phenotypic resistance to vancomycin was detected in 30.8% of the CoNS isolates, which is higher
than what was previously reported in Egypt in CoNS from chicken meat (27.8%) [6] and human clinical
isolates (15.5%) [5]. Globally, much lower or no resistance to vancomycin was recorded in CoNS, both
in humans [35] and broiler chicken isolates [36]. Despite the phenotypic resistance to vancomycin,
the vanA gene was not detected in any of the isolates by PCR, similar to that described in previous
studies [21,22].
The aac-aphD gene is associated with aminoglycoside resistance [40]. In this study, aac-aphD
gene was detected in 41.9% and 20.7% of gentamicin- and amikacin-resistant isolates, respectively.
A previous investigation detected aac-aphD in 30.0% of CoNS isolated from clinical samples [21].
The inconsistency between phenotypic antibiotic resistance and the presence of resistance-associated
genes is supported by previous studies documenting that both are not typically linked [41]. This
phenomenon could be attributed to many factors, such as the presence of other resistance-associated
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genes, the absence of expression of some resistance-encoding genes, or multidrug resistance eﬄux
pumps [42].
On the other hand, there was a perfect correlation between phenotypic resistance to erythromycin
and the carriage of the erm(C) gene. All isolates resistant to erythromycin were carrying the erm(C)
gene. Additionally, 41% of these isolates were positive for presence of erm(B) by PCR. Moreover, two
isolates (S. arlettae and S. lentus) carried erm(C), erm(B), and erm(A) genes. Different rates were recorded
for erm(C) and erm(A) in CoNS isolated from clinical samples [43] and for erm(B) and erm(C) in CoNS
isolated from chickens, ducks, and pigs in China [44].
Interestingly, resistance was recorded in this investigation against drugs that are not used in
veterinary medicine in Egypt, such as daptomycin, tigecycline, moxifloxacin, and linezolid, with
resistance rates of 89.7%, 87.2%, 82%, and 79.5%, respectively.
Linezolid is one of the last-resort antimicrobial agents for the control of serious infections caused
by methicillin-resistant staphylococci in humans [8]. Incidence of linezolid resistance in CoNS is
growing faster than in S. aureus. This increased resistance in CoNS could be attributed to the higher and
easier ability of CoNS to acquire and develop resistance determinants following linezolid exposure [8].
More worrisome is the very limited treatment options for linezolid-resistant isolates, which include
daptomycin and tigecycline [8].
Here, the phenotypic resistance to linezolid was recorded among different CoNS isolated from
apparently healthy turkeys. The rate was much higher than what was recorded in all previous
studies reporting drug resistance in CoNS isolated from humans (8.9%) [12] or total sensitivity [35].
No resistance against linezolid was detected previously in CoNS isolates from poultry, calves,
and pigs [14,36]. It is worth mentioning that linezolid resistance has never been reported in Egypt,
neither in humans nor in animals.
The cfr gene is associated with linezolid resistance [8] as well as resistance to other classes of
antibiotics (oxazolidinones, phenicols, lincosamides, pleuromutilins, and streptogramin A) [9]. CoNS
were identified as the most common organisms harboring the cfr gene, and the gene was previously
identified among them [45].
In this study, 35.4% and 29.7% of isolates resistant to linezolid and chloramphenicol carried the
cfr gene, respectively. The cfr gene was identified in 25.0% of linezolid-resistant CoNS isolated from
pigs [46] and 1.4% from humans [47]. The cfr gene was identified in CoNS isolated from chicken meat
in Egypt [6] and in methicillin-resistant CoNS (MRCoNS) isolates obtained from chickens, ducks,
and pigs in China [44].
The optrA gene proved to be associated with linezolid and phenicol resistance [10]. Previous studies
have reported the correlation between linezolid resistance and the carriage of optrA gene in CoNS of
porcine origin [11]. In this study, the optrA gene was carried by 38.7% of linezolid-resistant CoNS.
Coexisting carriage of optrA and cfr genes in CoNS isolated from pigs in China [11] was confirmed
in this study.
The valS gene was identified in 79.5% of isolates. It was noticed here that all isolates harboring two
or three genes of the optrA operon (cfr, optrA, and valS) were highly resistant to linezolid. All isolates
possessing the cfr gene were carrying the valS gene.
The U.S. Food and Drug Administration (FDA) approved daptomycin and tigecycline as alternatives
to linezolid as treatment options for infections caused by methicillin- and vancomycin-resistant
organisms [12,13].
Many studies have stated that linezolid-resistant Staphylococcus isolates are still susceptible to
daptomycin and tigecycline [8,12,13]. However, alarming studies have now reported the resistance to
daptomycin in CoNS in human medicine [16]. It is important to mention that daptomycin resistance is
still not reported in veterinary practice. Hence, the resistance rate of daptomycin in CoNS from healthy
turkeys was very high (89.7%) in this study. It might be assumed that a transmission of resistant CoNS
from human source to poultry has occurred.
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Tigecycline is the first glycylcycline antimicrobial agent that is highly active against many
multi-drug-resistant bacteria, including MRSA. Most of the recent studies recorded no resistance to
tigecycline among CoNS isolated from clinical isolates of human origin [21]. In this study, the phenotypic
resistance to tigecycline among turkey isolates was 87.2%.
The emergence of high antimicrobial resistance to linezolid, daptomycin, and tigecyclin in the
CoNS isolates in this study is suspected to be from human source as the hygienic measures in these
poultry farms were of moderate or low standards and permitted workers to move between flocks.
This hypothesis is strongly supported by the isolation of CoNS of human origin (S. epidermidis and
S. saprophyticus) from turkey samples in this study.
Furthermore, the improper use and availability of antimicrobial agents, especially linezolid,
daptomycin, and/or tigecyclin in human practice in Egypt without any prescription as a last choice for
infection treatment may lead to the rapid development of resistance against these groups.
On the other hand, the cross-resistance and transfer of resistance genes from other resistant
bacteria and the role of mobile genetic elements spreading among CoNS cannot be ignored.
In veterinary practice, linezolid, daptomycin, and tigecyclin are not frequently applied in
commercial poultry production in Egypt as these drugs are still highly expensive when compared to
other available antimicrobial agents. Although the resistant CoNS isolated in this study were from
poultry flocks, it does not prove that poultry is the source of infection, and it could have actually
originated from other sources, such as humans or the environment. Therefore, further investigations
should be performed to study the molecular epidemiology of the CoNS strains in order to prove the
genetic relationship between CoNS isolated from poultry, the environment, and humans.
The potential of natural products is significant in the efforts to bridge the large gap between needs
and available treatments, especially in terms of antimicriobial drugs, and may serve as an alternative
for the treatment and/or prevention of resistant pathogens [48].
5. Conclusions
Despite the fact that research interest in CoNS has been increasing in recent years, there are very
few data available on the prevalence and resistance profiles of CoNS in Egypt. The misuse of antibiotics
in turkey farms and bad sanitary conditions could lead to selection pressure, development, and spread
of resistant strains between turkeys and humans. This study has demonstrated that poultry can act as
a vector for CoNS harboring antimicrobial resistance genes. Multi-drug-resistant CoNS are a threat in
both humans and veterinary medicine.
This study is the first report on antimicrobial resistance in CoNS isolated from healthy turkeys in
Egypt. The data obtained can be used to develop guidelines for monitoring and prevention programs.
The study highlights the detection of highly linezolid-resistant CoNS and its associated resistance genes.
Whole-genome sequencing would be an important tool to expand our knowledge about linezolid and
daptomycin resistance and their genetic basis.
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